-
Clinical Update 10/04/2022 Problem With a Preventive Drug EVUSHELD (tixagevimab with cilgavimab) is the only product authorized for the pre-exposure prevention of COVID-19, but evidence shows it may provide less protection against Omicron variants compared to earlier strains
Patients of all sizes The effects of GLP-1 injections are effective and safe for patients of all ages, BMIs, races, and ethnicities
Doctors and scientists are calling for rigorous human studies to determine the long-term safety of the Wolverine Stack
This includes regular monitoring and lifestyle changes
For example, those who are candidates for Wegovy meet the FDA requirements of having a BMI (body mass index) of 30 or more or 27 or more with a weight-related complication, such as hypertension or [high cholesterol], says Tom Wadden, Ph.D., a psychologist and professor at University of Pennsylvania, in Philadelphia, who studies obesity treatments